IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2006;47:4316-4322.)
© 2006 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.05-1415
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hopkinson, A.
Right arrow Articles by Dua, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hopkinson, A.
Right arrow Articles by Dua, H. S.

Amniotic Membrane for Ocular Surface Reconstruction: Donor Variations and the Effect of Handling on TGF-ß Content

Andrew Hopkinson,1 Richard S. McIntosh,1 Patrick J. Tighe,1 David K. James,2 and Harminder S. Dua1

1From the Division of Ophthalmology and Visual Sciences and 2Foetomaternal Medicine, University Hospital Nottingham, Queen’s Medical Centre, Nottingham, United Kingdom.

PURPOSE. Amniotic membrane (AM) transplantation is an accepted procedure in ocular surgery. However, little is known of the interdonor and intradonor variability within the membrane. In addition, the effects of the methods of processing, storage, and preoperative preparation on the membrane are not fully elucidated. The purpose of this study was to use TGF-ß as an example to investigate interdonor and intradonor variability and to determine the effect of "handling " on TGF-ß1 within fresh, processed and stored, and transplantation-ready AM (TRAM).

METHODS. Seventeen human AMs, both fresh and handled, were analyzed for TGF-ß1 by real-time polymerase chain reaction, immunohistochemistry, SDS-PAGE, and Western blotting.

RESULTS. TGF-ß1 was the highest normalized expressed isoform of TGF-ß in all samples, but it varied between membranes of different donors and at different sites within the same membrane. The highest concentration was noted in the spongy layer. Removal of the spongy layer successfully removed the bulk of TGF-ß1 from TRAM. Latency-associated protein (LAP) and a latent TGF-ß–binding protein (LTBP) were also detected.

CONCLUSION. TGF-ß1 is present in various regulatory forms in the AM. A degree of intermembrane and intramembrane variation is modified by handling. Unless a standardized protocol is adopted that delivers a membrane with consistent constituents, clinical outcomes may vary and comparisons may be invalid.




This article has been cited by other articles:


Home page
 IOVSHome page
A. Abedin, I. Mohammed, A. Hopkinson, and H. S. Dua
A Novel Antimicrobial Peptide on the Ocular Surface Shows Decreased Expression in Inflammation and Infection
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 28 - 33.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Association for Research in Vision and Ophthalmology